Top ten stories in the pharmaceutical industry this week
August 5, 2016Medical Communications, Research and Development Actavis, Bioelectronics, CDF, Celgne, EMA, GSK, GlaxoSmithKline, Innovate UK, Medivation, NICE, Novartis, Roche, Sanofi, Teva, appointments, apremilast, biog, breast cancer, brexit, google, pharmaceutical industry, rheumatoid arthritis, sarilumab, top ten
It’s Friday, and we’ve seen some big developments in the industry’s headlines throughout the week, from news of Glaxo-Smith-Kilne’s new …
Novo Nordisk diabetes drug Victoza fails to reduce heart failure risk
August 5, 2016Medical Communications, Research and Development Eli Lily, Novo Nordisk, Victoza, diabetes, heart failure
Novo Nordisk’s diabetes drug Victoza (liraglutide), which was found to cut cardiovascular risks in sufferers of heart disease, has failed …
Majority of US patients’ groups supporting pharma against Medicare reforms received industry funding, claims report
August 5, 2016Medical Communications, Research and Development medicare reform, patients' groups, public citizen
An overwhelming majority of US patients’ groups who supported the pharmaceutical industry in opposing Medicare part B pricing reforms receive …
Eylea sales jump helps boost Regeneron in Q2 results
August 5, 2016Medical Communications, Research and Development 2016, Eylea, Q2, Regeneron, results
Regeneron Pharmaceuticals has published positive Q2 results with a 27% rise in Eylea (aflibercept) sales in the US helping to …
NICE recommends Cosentyx in ankylosing spondylitis
August 4, 2016Research and Development, Sales and Marketing Cosentyx, NICE, Novartis, ankylosing spondylitis
Novartis has announced that the National Institute for Health and Care Excellence (NICE) has recommended Cosentyx (secukinumab) to treat adults …
Merck Q2 results beat analyst estimates
August 4, 2016Medical Communications, Sales and Marketing Merck, financial results
Germany pharmaceutical firm Merck has announced its fiscal results for Q2 2016, beating analyst estimates with earnings before interest, taxes, …
NIH launches test of investigational human Zika vaccine
August 4, 2016Research and Development Vaccine, Zika virus
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has begun the clinical …
FDA determines Xiamen Origin Biotech wilfully lied to inspectors and customers
August 4, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Xiamen Origin Biotech
The US Food and Drug Administration (FDA) carried out an inspection of Chinese drug manufacturer Xiamen Origin Biotech, finding the …
Bad news for Adaptimmune as partial clinical hold placed on T-cell oncology trial
August 4, 2016Research and Development Adaptimmune, T cell, oncology, t-cell
Adaptimmune Therapeutics has received notice from the US Food and Drug Administration (FDA) that a partial clinical hold has been …
American pharmacy adds 35 products to list of excluded drugs
August 4, 2016Sales and Marketing Drug pricing, cvs health, excluded drugs, hyperinflationary
American pharmacy chain CVS Health has added 35 products to its list of excluded drugs and will not cover certain …
Roche cuts ties with Inovio in hepatitis B development
August 3, 2016Research and Development Inovio, Roche, hepatitis B
Inovio Pharmaceuticals has announced that it will independently continue development of hepatitis B immunotherapy, INO-1800, after Swiss drugmaker Roche issued …
Takeover rumours send Biogen’s stock soaring
August 3, 2016Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Biogen, MSD, rumours, takeover
Rumours have begun to circulate that companies including MSD and Allergan are plotting a takeover bid for Biogen, after a …
Celgene’s Otezla approved for NHS use
August 3, 2016Research and Development, Sales and Marketing Celgene, NHS, NICE, apremilast
NICE has published draft guidance recommending the use of Celgene’s Otezla (apremilast) for use on the NHS for treatment of …
Teva completes $40 billion acquisition of Actavis Generics
August 3, 2016Research and Development, Sales and Marketing Actavis, Allergan, Teva, acqusition, generics
Teva has announced that it has completed its acquisition of Actavis Generics, a subsidiary of Allergan, in a transaction valued …
MSD scores EU approval for Keytruda in lung cancer
August 3, 2016Research and Development, Sales and Marketing EU, MSD, Merck, approval, keytruda, lung cancer
MSD, called Merck in the US and Canada, has announced that the European Commission has approved Keytruda (pembrolizumab) for patients …
Breakthrough therapy designation for Novartis in advanced breast cancer treatment
August 3, 2016Research and Development, Sales and Marketing Breakthrough Therapy Designation, FDA, LEE011, Novartis, ribociclib
Novartis has announced that the US Food and Drug Administration (FDA) has granted a breakthrough therapy designation to LEE011 (ribociclib) …
Shire Q2 results outpace forecasts with 56% revenue growth
August 2, 2016Research and Development, Sales and Marketing Baxalta, Shire, financial report
Shire has announced its fiscal results for Q2 2016, reporting a strong quarter with a 56% growth in total revenues …
Revenue rises at Pfizer as Ibrance and Xeljanz beat sales expectations
August 2, 2016Research and Development, Sales and Marketing 2016, Pfizer, Prevnar, Q2, Xeljanz, ibrance, results
Pfizer has published its Q2 results, which show revenues rising 11% with new drugs helping to drive the growth and …
Landmark UK ruling as judge rules PrEP can be funded on NHS
August 2, 2016Manufacturing and Production, Research and Development, Sales and Marketing Judge, NHS, PrEP, UK, available, ruling
A London high court judge has ruled in favour of a challenge brought by the National Aids Trust to allow …
Joint Article on Hydrogen Peroxide Efficacy Published in Letters in Applied Microbiology
August 2, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wickham laboratories
Wickham Laboratories Ltd is pleased to announce the publication of a joint study with Bioquell on the efficacy of disinfection …
